Niederer Kraft Frey advised the banking syndicate on a USD 3.65 billion term and revolving credit facilities agreement for Galderma group in connection with its successful IPO on SIX Swiss Exchange on 22 March 2024.

Galderma is the pure-play dermatology category leader, present in approximately 90 countries delivering an innovative, science-based portfolio of premium brands and services that span the full spectrum of the fast-growing dermatology market.

Allen & Overy (London) acted as lead counsel to the banking consortium in this financing transaction.

The NKF team advising the banking syndicate was led by Transactions partners Philip Spoerlé and Adrian Koller, working with associates Reto Seiler, Manuel Hirlinger and Selim Lötscher (all M&A/Finance), as well as partner Markus Kronauer (Tax).